Haut- und Weichteilinfektionen – Erysipel, Phlegmone und Fasziitis

Zusammenfassung

Haut- und Weichteilinfektionen umfassen eine heterogene Gruppe von Erkrankungen, die zu den häufigsten Infektionen in der ambulanten und stationären Praxis gehören. Zu unterscheiden sind leichte, oberflächliche von schweren und komplizierten Erkrankungen. Letztere erfordern neben einer antiinfektiven Therapie grundsätzlich eine (unverzügliche) chirurgische Behandlung, deren Zeitpunkt und Radikalität bei der nekrotisierenden Fasziitis für die Prognose entscheidend sind. Insbesondere an den unteren Extremitäten kann die Differenzialdiagnose schwierig sein. Da die üblichen serologischen Infektparameter unspezifisch sind, steht im Vordergrund eine genaue Anamnese und die klinische Untersuchung. Bildgebende Verfahren können ergänzend erfolgen, dürfen die dringlich notwendige operative Therapie aber nicht verzögern.

Abstract

Skin and soft tissue infections comprise a heterogeneous group of diseases that are among the most common infections in outpatient and inpatient practice. A distinction must be made between mild, superficial diseases and servere and complicated diseases. In addition to anti-infective therapy, severe and complicated infections require (immediate) surgical treatment, the timing and radicalness of which determine the prognosis especially for necrotizing fasciitis. Differential diagnosis can be difficult, particularly in the lower extremities. Since the usual serological infection parameters are non-specific, the focus is on a precise anamnesis and clinical examination. Imaging procedures can be used in addition, but must not delay the urgently necessary surgical treatment.

Publikationsverlauf

Artikel online veröffentlicht:
08. Mai 2024

• Literatur

• 1 Jones ME, Karlowsky JA, Draghi DC. et al. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 2003; 22: 406-419
• 2 Suaya JA, Mera RM, Cassidy A. et al. Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect Dis 2014; 14: 296
• 3 Edelsberg J, Taneja C, Zervos M. et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009; 15: 1516-1518
• 4 Pallin DJ, Espinola JA, Leung DY. et al. Epidemiology of dermatitis and skin infections in United States physicians’ offices, 1993–2005. Clin Infect Dis 2009; 49: 901-907
• 5 Pallin DJ, Egan DJ, Pelletier AJ. et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008; 51: 291-298
• 6 Engel C, Brunkhorst FM, Bone HG. et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007; 33: 606-618
• 7 McNamara DR, Tleyjeh IM, Berbari EF. et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. Mayo Clin Proc 2007; 82: 817-821
• 8 Bartholomeeusen S, Vandenbroucke J, Truyers C. et al. Epidemiology and comorbidity of erysipelas in primary care. Dermatology 2007; 215: 118-122
• 9 Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44: 705-710
• 10 Lamagni TL, Darenberg J, Luca-Harari B. et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46: 2359-2367
• 11 Herr M, Grabein B, Palm H-G. et al. Nekrotisierende Fasziitis. Unfallchirurg 2001; 114: 197-216
• 12 Eckhard M, Lawall H, Lobmann R. Gesundheitsbericht 2022 der AG Diabetischer Fuß Diabetes und Fußprobleme in Deutschland 2021: ein Update. ISSN 1614-824X.
• 13 Kingston D, Seal DV. ) Current hypotheses on synergistic microbial gangrene. Br J Surg 1990; 77: 260-264
• 14 Kujath P, Eckmann E, Graninger W. et al. Kapitel 9. Haut- und Weichgewebe-, Knochen- und Gelenkinfektionen. In: Klaus-Friedrich Bodmann, Béatrice Grabein und die Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2010. Chemother J 2010; 19: 179-255
• 15 AWMF Leitlinie Nr.: 013/038 Diagnostik und Therapie Staphylococcus aureus bedingter Infektionen der Haut und Schleimhäute.
• 16 Sunderkötter C, Becker K, Eckmann C. et al. Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Haut- und Weichgewebeinfektionen. GMSInfectDis 2020; 8: Doc11
• 17 Stevens DL, Bisno AL, Chambers HF. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014; 59: 147-159
• 18 Swain R, Hatcher J, Azadian B. et al. A five-year review of necrotizing fasciitis in a tertiary referral unit. Ann R Coll Surg Engl 2013; 95: 57-60
• 19 Lipsky BA, Berendt AR, Cornia PB. et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: e132-e173
• 20 Wong CH, Khin LW, Heng KS. et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32: 1535-1541
• 21 Fernando SM, Tran A, Cheng W. et al. Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and metaanalysis. Ann Surg 2019; 269: 58-65
• 22 Borschitz T, Schlicht S, Siegel E. et al. Improvement of a clinical score for necrotizing fasciitis: ‘pain out of proportion’ and high CRP levels aid the diagnosis. PLoS ONE 2015; 10: e0132775
• 23 Sartelli M, Guirao X, Hardcastle TC. et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World Journal of Emergency Surgery 2018; 13: 58
• 24 Yen ZS, Wang HP, Ma HM. et al. Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med 2002; 9: 1448-1451
• 25 AWMF Leitlinie Nr.: 013/100 Differentialdiagnostik akuter und chronischer Rötungen im Bereich der Unterschenkel.
• 26 Dupuy A, Benchikhi H, Roujeau JC. et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999; 318: 1591-1594
• 27 Björnsdóttir S, Gottfredsson M, Thórisdóttir AS. et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis 2005; 41: 1416-1422
• 28 Perl B, Gottehrer NP, Raveh D. et al. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 1999; 29: 1483-1488
• 29 Long B, Koyfman A. Best clinical practice: blood culture utility in the emergency department. J Emerg Med 2016; 51: 529-539
• 30 Taniguchi T, Tsuha S, Shiiki S. et al. High yield of blood cultures in the etiologic diagnosis of cellulitis, erysipelas, and cutaneous abscess in elderly patients. Open Forum Infect Dis 2022; 9: ofac317
• 31 Hook 3rd EW, Hooton TM, Horton CA. et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986; 146: 295-297
• 32 Duvanel T, Auckenthaler R, Rohner P. et al. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989; 149: 293-296
• 33 McNamara DR, Tleyjeh IM, Berbari EF. et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med 2007; 167: 709-715
• 34 Jorup-Rönström C, Britton S. Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection 1987; 15: 105-106
• 35 Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of thelower leg: a series with community follow-up. Br J Dermatol 2006; 155: 947-950
• 36 Darenberg J, Luca-Harari B, Jasir A. et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007; 45: 450-458
• 37 Luca-Harari B, Darenberg J, Neal S. et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2009; 47: 1155-1165
• 38 Miller LG, Perdreau-Remington F, Rieg G. et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352: 1445-1453
• 39 Wong CH, Chang HC, Pasupathy S. et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85: 1454-1460
• 40 Misiakos EP, Bagias G, Patapis P. et al. Current concepts in the management of necrotizing fasciitis. Front Surg 2014; 1: 36
• 41 Prompers L, Huijberts M, Apelqvist J. et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25
• 42 Richard JL, Lavigne JP, Got I. et al. Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study. Diabetes Metab 2011; 37: 208-215
• 43 Lavery LA, Armstrong DG, Murdoch DP. et al. Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system. Clin Infect Dis 2007; 44: 562-565
• 44 Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952; 13: 389-399
• 45 Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999; 18: 1096-1100
• 46 Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. South Med J 2003; 96: 968-973
• 47 Carapetis JR, Jacoby P, Carville K. et al. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections. Clin Infect Dis 2014; 59: 358-365
• 48 Diep BA, Afasizheva A, Le HN. et al. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J Infect Dis 2013; 208: 75-82
• 49 Okoye O, Talving P, Lam L. et al. Timing of redébridement after initial source control impacts survival in necrotizing soft tissue infection. Am Surg 2013; 79: 1081-1085
• 50 Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 2004; 139: 1339
• 51 Brodt H-R. Antibiotika-Therapie. Klinik und Praxis der antiinfektiösen Behandlung. 12. Aufl.. Stuttgart: Schattauer; 2013. ISBN: 978-3-7945-2574-4
• 52 Bodmann KF, Grabein B, Kresken M. et al. S2k-Leitlinie Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2018. 2. aktualisierte Version, erstellt am 25. Juli 2019. AWMF Registernummer 082-006. Zugriff am 05. Januar 2024 unter: https://www.awmf.org/leitlinien/detail/ll/082-006.html